Crystal Crop Protection has officially launched its initial public offering (IPO), inviting investors to subscribe to its Rs 455.49 crore public issue. The subscription window, which opened on November 18, 2026, will remain accessible until November 20, 2026. As a significant player in the Indian agrochemical and seed solutions sector, the company is looking to leverage public capital to strengthen its balance sheet and pursue strategic growth initiatives.
IPO Structure and Essential Details
The company has established a price band of Rs 259–272 per equity share. The total issue size of Rs 455.49 crore is structured as a mix of a fresh issue and an offer for sale (OFS). The fresh issue accounts for Rs 354.77 crore (approximately 1.31 crore shares), while the OFS component totals Rs 100.71 crore (37.03 lakh shares). Retail investors are required to apply in lots of 55 shares, meaning the minimum investment at the upper end of the price band is Rs 14,960.
| IPO Parameter | Value |
|---|---|
| Price Band | Rs 259 – Rs 272 |
| Lot Size | 55 shares |
| Issue Size | Rs 455.49 crore |
| Listing Date | November 26, 2026 |
| Registrar | MUFG Intime India |
The IPO allotment process is expected to conclude on November 23, 2026, with the shares slated to debut on the NSE and BSE on November 26, 2026. The company has also extended an employee reservation portion, featuring a discount of Rs 25 per share for eligible participants.
Business Model and Market Presence
Crystal Crop Protection operates an integrated business model spanning the entire value chain of crop solutions, including R&D, seed breeding, manufacturing, and distribution. Its portfolio is expansive, covering herbicides, fungicides, insecticides, and bio-stimulants. Beyond crop protection, the company maintains a robust seed division that covers field crops, vegetables, and flowers.
The company manages a vast distribution network, supported by over 13,000 distributors and 36 distribution centres across India. Its manufacturing capabilities are substantial; as of September 30, 2025, the company reported formulation manufacturing capacity of 75,962 MT and technical manufacturing capacity of 3,456 MT. This infrastructure serves both domestic demand and international markets, with exports reaching regions including Africa, Asia, Japan, and the US.
Financial Analysis and Valuation
The company’s valuation metrics suggest a premium pricing strategy. At the upper price band, the IPO is valued at 24.59 times its diluted FY26 earnings per share (EPS). This compares to a valuation of 23.42 times at the floor price. When evaluated against the industry peer group average P/E multiple of 20.07 times, it is evident that the issue is priced at a premium. The weighted average return on net worth (RoNW) for the previous three financial years is reported at 7.06%.
A significant portion of the fresh issue proceeds is allocated to debt reduction. Specifically, Rs 31.29 crore will be used for the repayment of company borrowings, with an additional Rs 2.21 crore invested into its material subsidiary, Saffire Crop Science Private Limited, for similar debt-servicing purposes. The remainder of the capital is earmarked for inorganic growth through strategic acquisitions and general corporate objectives.
Grey Market Sentiment
The grey market premium (GMP) currently serves as an unofficial indicator of investor sentiment. The latest reports place the GMP at Rs 13, representing a 5% premium over the upper price band of Rs 272. Based on this, the calculated indication for the listing price stands at Rs 285. It is essential to note that the GMP is an unofficial market metric and does not guarantee listing performance or future stock movement.
| Metric | Details |
|---|---|
| Current GMP | Rs 13 |
| Premium Percentage | 5% |
| Calculated Listing Indication | Rs 285 |
The market’s interest in this IPO reflects a broader focus on the sustainability of the agrochemical sector. While the valuation is considered full by some analysts, the company’s commitment to R&D and its established footprint in seed breeding remain central to its long-term growth narrative.
Key Takeaways
- The IPO is open for subscription from November 18 to November 20, 2026.
- The price band is set at Rs 259–272 per share with a lot size of 55 shares.
- The company is valued at 24.59 times its FY26 EPS at the upper price band, which is a premium to the industry average of 20.07 times.
- A total of Rs 33.50 crore from the IPO proceeds is designated for debt repayment and strategic growth.
- Grey market indicators suggest a modest 5% potential listing gain, though this remains an unofficial estimate.
- The company operates a comprehensive business model with 13,000+ distributors and significant manufacturing capacities.
Frequently Asked Questions
The price band for the IPO is fixed at Rs 259–272 per share.
Retail investors must apply for a minimum lot size of 55 shares, which amounts to an investment of Rs 14,960 at the upper price band.
The company's shares are proposed to list on the NSE and BSE on November 26, 2026.
The current grey market premium (GMP) is Rs 13, which is approximately 5% over the upper price band of Rs 272.
The proceeds are planned for the repayment/pre-payment of borrowings of the company and its subsidiary, Saffire Crop Science, as well as for inorganic growth and general corporate purposes.
At the upper price band, the company is valued at 24.59 times its diluted FY26 earnings per share (EPS).
Yes, eligible employees participating in the employee reservation portion receive a discount of Rs 25 per share.